University of Maryland School of Pharmacy Pharmacotherapy (PT) Rounds Schedule (2021-2022)

Date Presenter Institution Topic
Tue, Sept. 14, 2021 J Emily Von Bulow, PharmD University of Maryland  Shaken, not stirred: Is there a perfect cocktail for migraine and headache relief?
Marisa Rinehart, PharmD University of Maryland  The PharmD - New on Our Menu: Long Acting Injectable Antipsychotic Shots
Tue, Sept. 21, 2021 Cecilia Li, PharmD University of Maryland  Big Guns Leave Big Holes: When to Pull the Trigger? Evaluation of risk factors for extended-spectrum betalactamase (ESBL) bacteremia 
Irene Ruiz, PharmD  University of Maryland  Bypassing blood products: Use of FEIBA in pediatric cardiac patients
Tue, Sept. 28, 2021 Bobbie Nguyen, PharmD  University of Maryland  DO-AC or DON’T? Direct Oral Anticoagulant Use in the Oldest-Old Adults with Atrial Fibrillation
Richard Rovelli, PharmD University of Maryland  Cardiac Amyloidosis - What's the mATTeR with their Heart?
Tue, Oct. 05, 2021 Nicholas Husak, PharmD University of Maryland  One Fab, Two Fab, Old Fab, New Fab: Choosing an Antivenom for North
American Crotalinae Envenomation
Angela Lam, PharmD  University of Maryland  The use of glucarpidase therapy in methotrexate toxicity 
Tue, Oct. 12, 2021 Amanda Loomis, PharmD University of Maryland  Give it a shot? Updates to pneumococcal vaccine recommendations in older adults
Merton Lee, PharmD University of Maryland  Optimizing Antihypertensives:
Prescribing and Deprescribing
Tue, Oct. 19, 2021 Xiao Qing Ye, PharmD VAMHCS New hope for Alzheimer’s Disease?
Clinical review of aducanumab and its
potential place in therapy
Jonathan Green, PharmD  VAMHCS You got to be kidney me! Emerging Therapy in the Management of CKD in
Tue, Oct. 26, 2021 Joshua Borris, PharmD University of Maryland Buprenorphine is Playing With Our Emotions 
Sydney Israel, PharmD University of Maryland PEA? Where have you been all my life?
Tue, Nov. 02, 2021 Emily Garcia, PharmD  University of Maryland Saved by the Bela: Examining the impact of belatacept therapy on donor specific antibody formation
Karen Huang, PharmD  University of Maryland Immunosuppression in the Failing Kidney Transplant: Should I Stay or Should I Go?
Tue, Nov. 09, 2021 Jessica Cercone, PharmD  University of Maryland Should we join the block party? Beta blockers in septic shock
Nabila Faridi, PharmD University of Maryland Where are the tides? New GLP-1 Receptor Agonist for Type 2 Diabetes
Tue, Nov. 16, 2021 Chelsey Axelrod, PharmD  University of Maryland Expanding Your Mind: The Use of Psychedelics for the Treatment of Psychiatric Disorders
Tue, Dec. 21, 2021 Allison Loi, PharmD University of Maryland /
Shaking up Shingles: Protection for Immunocompromised Patients
Wed, Jan. 05, 2022 Reid LaPlante, PharmD University of Maryland Beta Think Twice: Beta-Lactam Dosing Strategies within the Critically Ill
Wed, Jan. 12, 2022 Farideh Sistani, PharmD University of Maryland Telemental health policy changes during and after the COVD-19 pandemic
Wed, Jan. 19, 2022 Sumeen Mirza, PharmD University of Maryland C(MV) You Later- With a Focus on Maribavir
Wed, Jan. 26, 2022 Ami Patel, PharmD University of Maryland My Heart Will Go On: Neurohormonal Blockade Following Left Ventricular Assist Device Implantation
Wed, Feb. 02, 2022 Ryan Nguyen, PharmD Sinai Hospital Keeping an Eye on STIs: Updates to the CDC’s Treatment Guidelines for
Sexually Transmitted Infections
Sara Hall, PharmD Sinai Hospital Updates to the use of
dexmedetomidine for sedation in critically ill patients 
Wed, Feb. 09, 2022 Ibtihal Makki, PharmD University of Maryland Bad Blood: DOACs vs. Warfarin (Antiphospholipid Syndrome Version)
(60 minute Version) 
Wed, Feb. 16, 2022 Cynthia Mock, PharmD  VAMHCS SGLT2 inhibitors for Diabetes, Heart Failure, now Hypertension?
Christian Macaspac, PharmD VAMHCS AFFIRMing the Benefits of IV Iron in Heart Failure
Wed, Feb. 23, 2022 Asma Ul Husna, PharmD GBMC Hot off the agar plate! - The role of imipenem-cilastatin-relebactam for
multi-drug resistant (MDR) pathogens in the inpatient setting. 
Brittany Olbert, PharmD GBMC DOACs are Weighing In: To load or Not to Load - Nuances of Prescribing
in Obesity
Wed, Mar. 02, 2022 Daniel Cericola, PharmD University of Maryland /
Hitting the Target; Post-Cardiac Arrest Care
Wed, Mar. 09, 2022 Nadia Adjin-Tettey, PharmD Frederick Memorial Hospital Optimizing Vancomycin Monitoring in Pediatrics: AUC vs Trough Monitoring
Sharon Vadapalli, PharmD Frederick Memorial Hospital The Weight is Over! Pharmacotherapy of Weight Loss Medications
Wed, Mar. 16, 2022 Chaya Lachman, PharmD Carroll Hospital Center JAK is back: revisiting Janus Kinase inhibitor indications and their recent cardiovascular safety concerns
Jahnavi Patel, PharmD  Medstar Harbor Hospital Paralytics Paradigm: Continuous vs. Intermittent
Wed, Mar. 30, 2022 Victoria Fusco, PharmD  MedStar Union Memorial
MRSA Nares and Indications for Use:
Is the Answer to Antibiotic Deescalation Under the Tip of Our
Wed, Apr. 06, 2022 Pari Majethia, PharmD  University of Maryland /
Direct Oral Anticoagulant Use in
Patients with Metastases 
Wed, Apr. 13, 2022 Clynton Musngi, PharmD Medstar Union Memorial
Will You (B)MI DOAC?: VTE Management with DOACs in Obesity
Lilly Lin, PharmD  Shady Grove Adventist TBA
Wed, May 04, 2022 Paige Gilk, PharmD  University of Maryland /
Prevention in an Injection: Cabotegravir for PrEP
Wed, May 11, 2022 Renee Mott, PharmD Suburban Hospital  VICTORY for vericiguat... or not? An Evaluation of Vericiguat in Heart Failure 
Sara Foreman, PharmD  Suburban Hospital  What’s the DIFFerence? The 2021 IDSA/SHEA Clostridioides difficile
Treatment Guideline Updates